Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Summary: The risk of stroke in atrial fibrillation (AF) needs to be assessed in each patient to determine the clinical and cost-effectiveness of thromboprophylaxis, with the aim of appropriate use of antithrombotic therapy. To achieve this, stroke risk factors in AF populations need to be identified and stroke risk stratification models have been devised on the basis of these risk factors. In this article, we firstly provide a systematic review of studies examining the attributable stroke risk of various clinical, demographic and echocardiographic patient characteristics in AF populations. Secondly, we performed a systematic review of published stroke risk stratification models, in terms of the results of the review of stroke risk factors and their ability to accurately discriminate between different levels of stroke risk. Thirdly, we review the health economic evidence relating to the cost-effectiveness of anticoagulation and antiplatelet therapy as thromboprophylaxis in AF patients. The studies included in the systematic review of stroke risk factors identified history of stroke or TIA, increasing age, hypertension and structural heart disease (left-ventricular dysfunction or hypertrophy) to be good predictors of stroke risk in AF patients. The evidence regarding diabetes mellitus, gender and other patient characteristics was less consistent. Three stroke risk stratification models were identified that were able to discriminate between different categories of stroke risk to at least 95% accuracy. Few models had addressed the cumulative nature of risk factors where a combination of risk factors would confer a greater risk than either factor alone. In patients at high risk of stroke, anticoagulation is cost effective, but not for those with a low risk of stroke. With the evidence available for stroke risk factors and the various alternative stroke risk stratification models, a review of these models in terms of the evidence on which they are devised and their performance in representative AF populations is important. The appropriate administration of thromboprophylaxis in AF patients would need to balance the risks and benefits of antithrombotic therapy with its cost-effectiveness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Stroke in AF Working Group attributed a RR of 1.7 (95% CI, 1.4-2.0)for stroke in patients with AF and diabetes, as well as an absolute stroke risk of 2-3.5% per year for non-anticoagulated patients in the same population.621”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [621]
In the citing paper
“The Stroke in AF Working Group attributed a RR of 1.7 (95% CI, 1.4-2.0)for stroke in patients with AF and diabetes, as well as an absolute stroke risk of 2-3.5% per year for non-anticoagulated patients in the same population.621”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [621]
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793 · cited 1×
“AF increases the risk of stroke by five-fold, and the use of anticoagulation reduces this risk by two-thirds whilst antiplatelet therapy reduces stroke by one-fifth (2, 3).”
BackgroundImpact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575 · cited 1×
“Atrial fibrillation (AF) is an independent risk factor for stroke and thromboembolism and results in an independent increase in mortality per se (1).”
BackgroundMant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Self-citationACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
Hylek, E. M., Evans-Molina, C., Shea, C., Henault, L. E., & Regan, S. (2007) · Circulation · doi:10.1161/circulationaha.106.653048 · Cited by 1,061
Wang, T. J., Massaro, J. M., Levy, D., Vasan, R. S., Wolf, P. A., D'Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 780
Gage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Go, A. S., Hylek, E. M., Chang, Y., Phillips, K. A., Henault, L. E., Capra, A. M., Jensvold, N. G., Selby, J. V., & Singer, D. E. (2003) · JAMA · doi:10.1001/jama.290.20.2685 · Cited by 703
Writing Committee Members, Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., et al. (2006) · Europace · doi:10.1093/europace/eul097 · Cited by 667
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,864
Self-citationRuff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
Self-citationYancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,899
Self-citationYancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Guidelines for the management of atrial fibrillation
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · EP Europace · doi:10.1093/europace/euq350 · Cited by 1,747
Self-citation2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Olesen, J. B., Lip, G. Y. H., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., Selmer, C., Ahlehoff, O., Olsen, A.-M. S., Gislason, G. H., et al. (2011) · BMJ · doi:10.1136/bmj.d124 · Cited by 1,428
“Patients with atrial fibrillation have a substantial risk of stroke, which is modified by the presence or absence of several risk factors.”
BackgroundSelf-citationPathophysiological mechanisms of atrial fibrillation: a translational appraisal
Schotten, U., Verheule, S., Kirchhof, P., & Goette, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2009 · Cited by 1,273
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr488 · Cited by 1,192
Self-citationAntithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M., Werring, D., et al. (2018) · Chest · doi:10.1016/j.chest.2018.07.040 · Cited by 939
Self-citationUnderuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Ogilvie, I. M., Newton, N., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.025 · Cited by 927
Self-citationAntithrombotic Therapy for Atrial Fibrillation
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., Hylek, E. M., Schulman, S., Go, A. S., Hughes, M., et al. (2012) · Chest · doi:10.1378/chest.11-2304 · Cited by 918
Self-citation(2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Steinhubl, S. R., Waalen, J., Edwards, A. M., Ariniello, L. M., Mehta, R. R., Ebner, G. S., Carter, C., Baca-Motes, K., Felicione, E., Sarich, T., et al. (2018) · JAMA · doi:10.1001/jama.2018.8102 · Cited by 539
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010) · Stroke · doi:10.1161/strokeaha.110.590257 · Cited by 491
Self-citationLip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-11-0876 · Cited by 400
“found evidence for structural heart disease (including prior myocardial infarction or cardiac dysfunction) and female sex as risk factors (14, 15).”
BackgroundSelf-citationGanesan, A. N., Chew, D. P., Hartshorne, T., Selvanayagam, J. B., Aylward, P. E., Sanders, P., & McGavigan, A. D. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw007 · Cited by 391
“–8 Stroke risk stratification in AF is therefore based around the concept that embolic risk is driven by patient-level risk factors rather than AF type.(9,10) To a large extent, this paradigm has been based on historical evidence demonstrating relative risk equivalence for stroke in between PAF and NPAF.”
BackgroundHusted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0403 · Cited by 364
Self-citationHusted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0443 · Cited by 365
“Other factors, such as peripheral artery disease (119-122), MI (123, 124), and age 65-74 (118), are also independent risk factors in AF for stroke and vascular events.”
BackgroundSelf-citationPlatelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke
NIESWANDT, B., PLEINES, I., & BENDER, M. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04361.x · Cited by 356
Lip, G. Y., Tse, H. F., & Lane, D. A. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61514-6 · Cited by 338
Self-citationHuber, K., Andreotti, F., Arnesen, H., Airaksinen, K. J., Cuisset, T., Kirchhof, P., Marín, F., & Lip, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-08-0580 · Cited by 303
Self-citationBiomarkers in atrial fibrillation: a clinical review
Hijazi, Z., Oldgren, J., Siegbahn, A., Granger, C. B., & Wallentin, L. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht024 · Cited by 298
“Systematic reviews have identified prior stroke/transient ischaemic attack/thromboembolism, older age, hypertension, diabetes, and structural heart disease as important risk factors.(10,11) Recently, vascular disease, age ≥65 years, and female gender were also added and now constitute the variables in”
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.020 · Cited by 288
VAN STAA, T. P., SETAKIS, E., DI TANNA, G. L., LANE, D. A., & LIP, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04085.x · Cited by 272
Self-citationFriberg, L., Benson, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · BMJ · doi:10.1136/bmj.e3522 · Cited by 268
Self-citationAtrial fibrillation prevalence revisited
Friberg, L., & Bergfeldt, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12114 · Cited by 255
Chan, P., Wong, C., Poh, Y. C., Pun, L., Leung, W. W., Wong, Y., Wong, M. M., Poh, M., Chu, D. W., & Siu, C. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003428 · Cited by 240
Stoll, G., Kleinschnitz, C., & Nieswandt, B. (2008) · Blood · doi:10.1182/blood-2008-04-144758 · Cited by 237
The Task Force on diabetes, P.-D. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114525548 · Cited by 236
Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., Oto, A., Potpara, T. S., Steffel, J., Marín, F., et al. (2017) · EP Europace · doi:10.1093/europace/eux091 · Cited by 219
Self-citationLopes, R. D., Al-Khatib, S. M., Wallentin, L., Yang, H., Ansell, J., Bahit, M. C., De Caterina, R., Dorian, P., Easton, J. D., Erol, C., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60986-6 · Cited by 206
Pancholy, S. B., Sharma, P. S., Pancholy, D. S., Patel, T. M., Callans, D. J., & Marchlinski, F. E. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.035 · Cited by 204
Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.220 · Cited by 199
Self-citationImproving Stroke Risk Stratification in Atrial Fibrillation
Lip, G. Y. H., & Halperin, J. L. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.013 · Cited by 185
Self-citationWagstaff, A. J., Overvad, T. F., Lip, G. Y. H., & Lane, D. A. (2014) · QJM · doi:10.1093/qjmed/hcu054 · Cited by 176
“Background Atrial fibrillation (AF) is an independent risk factor for stroke, increasing this risk 5-fold,(1) however this risk is not homogenous and is dependent on the presence or absence of a number of individual risk factors.(2) The incidence and prevalence of AF varies among men and women.”
BackgroundSelf-citationPisters, R., Lane, D. A., Marin, F., Camm, A. J., & Lip, G. Y. H. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1036 · Cited by 159
Self-citationImplications of the CHA2DS2-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial Fibrillation
Lip, G. Y. H. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.05.007 · Cited by 179
“These guidelines have (artificially) categorized stroke isk into ‘high’, ‘moderate’ or ‘low’ risk strata according to arious risk factors for stroke and thromboembolism derived rom nonwarfarin arms of clinical trial cohorts and cohort tudies.(1) Based on schemes such as the CHADS2 (Congestive eart failure, Hypertensio…”
BackgroundSelf-citationAre Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?
ZIMETBAUM, P. J., Thosani, A. J., Yu, H.-T., Xiong, Y., Lin, J., Kothawala, P., & Emons, M. F. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.015 · Cited by 155
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
MIKKELSEN, A. P., LINDHARDSEN, J., LIP, G. Y. H., GISLASON, G. H., TORP‐PEDERSEN, C., & OLESEN, J. B. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04853.x · Cited by 137
Self-citationWilke, T., Groth, A., Mueller, S., Pfannkuche, M., Verheyen, F., Linder, R., Maywald, U., Kohlmann, T., Feng, Y., BREITHARDT, G. E., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-11-0768 · Cited by 129
Body mass index and adverse events in patients with incident atrial fibrillation
Overvad, T. F., Rasmussen, L. H., Skjøth, F., Overvad, K., Lip, G. Y. H., & Larsen, T. B. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.11.024 · Cited by 127
Self-citationSuissa, L., Bertora, D., Lachaud, S., & Mahagne, M. H. (2009) · Stroke · doi:10.1161/strokeaha.109.552679 · Cited by 135
Suzuki, S. S., Yamashita, T., Okumura, K., Atarashi, H., Akao, M., Ogawa, H., & Inoue, H. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-1131 · Cited by 125
Female sex as an independent risk factor for stroke in atrial fibrillation: Possible mechanisms
Albert, C. M., Andreotti, F., Badimon, L., Van Gelder, I. C., Hylek, E. M., & Cove, C. L. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-04-0347 · Cited by 116
“Atrial fibrillation (AF) is an independent risk factor for thromboembolism and stroke (3) and although conflicting data exist, the balance of evidence suggests that female sex, after adjusting for stroke risk profile, is associated with a higher risk of stroke in the setting of AF (4–6).”
BackgroundReview of Stroke Thrombolytics
Bivard, A., Lin, L., & Parsonsb, M. W. (2013) · Journal of Stroke · doi:10.5853/jos.2013.15.2.90 · Cited by 115
“There are two blood coagulation cascades (intrinsic and extrinsic pathways), that have separate initial pathways but converge on a common pathway(9) (Figure 2).(10)”
BackgroundKirchhof, P., Bax, J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., Cosio, F., Crijns, H., Diener, H.-C., Goette, A., et al. (2009) · Europace · doi:10.1093/europace/eup124 · Cited by 111
Self-citationOlesen, J. B., Fauchier, L., Lane, D. A., Taillandier, S., & Lip, G. Y. H. (2011) · CHEST Journal · doi:10.1378/chest.11-0862 · Cited by 127
Self-citationPotpara, T. S., Polovina, M. M., Licina, M. M., Marinkovic, J. M., Prostran, M. S., & Lip, G. Y. H. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966713 · Cited by 102
Self-citationGender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment
Antonucci, E., Grifoni, E., Abbate, R., Gensini, G. F., Prisco, D., & Poli, D. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-10-0635 · Cited by 95
Charidimou, A., Shakeshaft, C., & Werring, D. J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00133 · Cited by 94
“However, this risk of ischemic stroke increases with the presence of other stroke risk factors (Hughes and Lip, 2008).”
BackgroundVascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study
Olesen, J. B., Lip, G. Y. H., Lane, D. A., Køber, L., Hansen, M. L., Karasoy, D., Hansen, C. M., Gislason, G., & Torp-Pedersen, C. T. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.024 · Cited by 102
Self-citationObesity, Diabetes and Atrial Fibrillation; Epidemiology, Mechanisms and Interventions
Asghar, O., Alam, U., Hayat, S. A., Aghamohammadzadeh, R., Heagerty, A. M., & Malik, R. A. (2012) · Current Cardiology Reviews · doi:10.2174/157340312803760749 · Cited by 101
Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
Lip, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04302.x · Cited by 105
Self-citationHankey, G. J., & Eikelboom, J. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70038-7 · Cited by 87
Lip, G. Y. H. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-01-0038 · Cited by 87
Self-citationAntithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
Alberts, M. J., Eikelboom, J. W., & Hankey, G. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70258-2 · Cited by 94
Guo, Y., Apostolakis, S. Z., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., & Lip, G. Y. H. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.052 · Cited by 87
“Vascular disease, including previous myocardial infarction (MI) and peripheral vascular disease (PVD) have previously been shown to increase the risk of stroke/TE in AF studies [12,24–27].”
BackgroundSelf-citationChan, P.-H., Wong, C.-K., Pun, L., Wong, Y.-F., Wong, M. M.-Y., Chu, D. W.-S., & Siu, C.-W. (2017) · Circulation · doi:10.1161/circulationaha.116.024439 · Cited by 79
Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review
Sankaranarayanan, R., Kirkwood, G., Dibb, K., & Garratt, C. J. (2013) · Cardiology Research and Practice · doi:10.1155/2013/976976 · Cited by 78
“However, the in�uence of age is underestimated by the CHADS2 system; recent studies have indicated that, amongst moderate risk patients with a CHADS2 score of 1, individuals over the age of 75 with isolated AF are at a higher risk of stroke than are younger patients with a single additional risk factor [138, 139].”
MethodFemale gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients
Lip, G., & Lane, D. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0106 · Cited by 78
Self-citationStroke Risk Stratification in a “Real-World” Elderly Anticoagulated Atrial Fibrillation Population
POLI, D., LIP, G. Y., ANTONUCCI, E., GRIFONI, E., & LANE, D. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01858.x · Cited by 77
Self-citationBang, C. N., Gislason, G., Greve, A. M., Bang, C. A., Lilja‐Cyron, A., Torp-Pedersen, C. T., Andersen, P. K., Køber, L., Devereux, R. B., & Wachtell, K. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000382 · Cited by 82
“This is supported by earlier observations including addition of age in CHA2DS2-VASc score (Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, Stroke/TIA, Vascular disease, Aged 65 to 74 years and female Sex [1 point for presence of each, except for 2 points for age ≥75 years and stroke/TIA]; sco…”
MethodHealey, J. S., Parkash, R., Pollak, T., Tsang, T. S. M., & Dorian, P. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.015 · Cited by 76
“Other moderate risk factors include female gender and peripheral vascular disease.(37) Many of these same conditions are also associated with an increased risk of bleeding.”
BackgroundProvidencia, R. A., Botelho, A., Trigo, J., Quintal, N., Nascimento, J. H. M., Mota, P. C., & Leitão‐Marques, A. (2011) · EP Europace · doi:10.1093/europace/eur272 · Cited by 82
Bertaglia, E., Blank, B., Blomström‐Lundqvist, C., Brandes, A., Cabanelas, N., Dan, G. A., Dichtl, W., Goette, A., de Groot, J. R., Lubiński, A., et al. (2019) · EP Europace · doi:10.1093/europace/euz172 · Cited by 80
Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation
Schirmer, S. H., Baumhäkel, M., Neuberger, H., Hohnloser, S. H., Gelder, I. C. V., Lip, G. Y. H., & Böhm, M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.017 · Cited by 76
Self-citationAlonso‐Coello, P., Montori, V. M., Díaz, M. G., Devereaux, P. J., Dalmau, G. M., Díez, A. I. F., Solà, I., Roura, M., Souto, J. C., Oliver, S., et al. (2014) · Health Expectations · doi:10.1111/hex.12201 · Cited by 84
Potpara, T., Polovina, M. M., Licina, M. M., Marinković, J., & Lip, G. Y. H. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft004 · Cited by 67
Self-citationEdwards, J. D., Healey, J. S., Fang, J., Yip, K., & Gladstone, D. J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013227 · Cited by 65
Lord, J., Willis, S., Eatock, J., Tappenden, P., Trapero‐Bertran, M., Miners, A. H., Crossan, C., Westby, M. J., Anagnostou, A., Taylor, S. J. E., et al. (2013) · Health Technology Assessment · doi:10.3310/hta17580 · Cited by 70
Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality.
Bordignon, S., Corti, M. C., & Bilato, C. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.467 · Cited by 108
Anandasundaram, B., Lane, D. A., Apostolakis, S. Z., & Lip, G. Y. H. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12177 · Cited by 64
Self-citationPamukçu, B., Lip, G. Y. H., & Lane, D. A. (2010) · Age and Ageing · doi:10.1093/ageing/afq059 · Cited by 59
Self-citationOrchard, J. J., Neubeck, L., Freedman, B., Li, J., Webster, R. J., Zwar, N. A., Gallagher, R. D., Ferguson, C., & Lowres, N. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010959 · Cited by 60
Sandhu, R. K., Hohnloser, S. H., Pfeffer, M. A., Yuan, F., Hart, R. G., Yusuf, S., Connolly, S. J., McAlister, F. A., & Healey, J. S. (2015) · Stroke · doi:10.1161/strokeaha.114.007140 · Cited by 56
Autonomous Control of Continuum Robot Manipulators for Complex Cardiac Ablation Tasks
Yip, M. C., Sganga, J., & Camarillo, D. B. (2016) · Journal of Medical Robotics Research · doi:10.1142/s2424905x17500027 · Cited by 53
Shiga, T., Naganuma, M., Nagao, T., Maruyama, K., Suzuki, A., Murasaki, K., & Hagiwara, N. (2015) · Journal of Arrhythmia · doi:10.1016/j.joa.2015.04.004 · Cited by 53
“Original Article Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study Tsuyoshi Shiga, MDa,n, Miyoko Naganuma, BScb, Takehiko Nagao, MDc, Kenji Maruyama, MDc, Atsushi Suzuki, MDa, Kagari Murasaki, MDa, Nobuhisa Hagiwara, MDa a…”
BackgroundThe World Heart Federation Roadmap for Nonvalvular Atrial Fibrillation
Murphy, A., Banerjee, A., BREITHARDT, G. E., Camm, A. J., Commerford, P., Freedman, B., González-Hermosillo, J. A., Halperin, J. L., Lau, C., Perel, P., et al. (2017) · Global Heart · doi:10.1016/j.gheart.2017.01.015 · Cited by 56
“The risk factors for stroke among AF patients for which there is an evidence base include prior stroke, transient ischemic attack, thromboembolism, age, hypertension, diabetes and structural heart disease [9,37,38].”
BackgroundAre the novel anticoagulants better than warfarin for patients with atrial fibrillation?
Hanley, C. M., & Kowey, P. R. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2015.01.23 · Cited by 51
Tomita, H., Okumura, K., Inoue, H., Atarashi, H., Yamashita, T., Origasa, H., Tsushima, E., & on behalf of the J-RHYTHM Registry Investigators (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0095 · Cited by 58
Rasmussen, L. E., Tveit, A., Jensen, E. C., Wessman, P., Panfilov, S., Wåhlander, K., & Olsson, B. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-07-0509 · Cited by 52
“Vitamin K antagonists (VKAs) have been the cornerstone of anticoagulation therapy for over 60 years, with their effectiveness established in many clinical trials (5, 6).”
BackgroundOral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
Potpara, T., & Lip, G. Y. H. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.003 · Cited by 58
Self-citationA comparison of entropy approaches for AF discrimination
Liu, C., Oster, J., Reinertsen, E., Li, Q., Zhao, L., Nemati, S., & Clifford, G. D. (2018) · Physiological Measurement · doi:10.1088/1361-6579/aacc48 · Cited by 52
Vinereanu, D., Stevens, S. R., Alexander, J. H., Al‐Khatib, S. M., Avezum, Á., Bahit, M. C., Granger, C. B., Lópes, R. D., Halvorsen, S., Hanna, M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv447 · Cited by 56
Pacing Treatment of Atrial Fibrillation Patients with Heart Failure
Huang, W., Su, L., & Wu, S. (2018) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2018.05.016 · Cited by 57
Stroke and Bleeding Risk in Atrial Fibrillation
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2014) · Korean Circulation Journal · doi:10.4070/kcj.2014.44.5.281 · Cited by 50
Self-citationPacheco, C., Mullen, K., Coutinho, T. A., Jaffer, S., Parry, M. J. E., Spall, H. G. C. V., Clavel, M.-A. A., Edwards, J. D., Sedlak, T., Norris, C. M., et al. (2021) · CJC Open · doi:10.1016/j.cjco.2021.11.006 · Cited by 58
Naccarelli, G. V., Johnston, S. S., Dalal, M. R., Lin, J., & Patel, P. P. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.009 · Cited by 46
“The Charlson co-morbidity index(9) and chronic disease score(10) were used to provide aggregate measures of co-morbidities, and the cumulative risk for stroke was assessed using the CHADS2 (congestive HF, hypertension, age 75 years, iabetes, and previous stroke) scoring system.(11,12) The use of medications and nonpha…”
MethodClinical outcomes of acute stroke patients with atrial fibrillation
Khoo, C. W., & Lip, G. Y. H. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.11 · Cited by 46
Self-citationRasmussen, L. H., Larsen, T. B., Due, K. M., Tjønneland, A. M., Overvad, K., & Lip, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04308.x · Cited by 48
Self-citationWhat are the costs of atrial fibrillation?
Blomstrom Lundqvist, C., Lip, G. Y. H., & Kirchhof, P. (2011) · Europace · doi:10.1093/europace/eur087 · Cited by 42
Self-citationOdum, L. E., Cochran, K. A., Aistrope, D. S., & Snella, K. A. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.2012.01023.x · Cited by 51
Wasmer, K., Köbe, J., Dechering, D. G., Milberg, P., Pott, C., Vogler, J., Stypmann, J., Waltenberger, J. L., Mönnig, G., BREITHARDT, G. E., et al. (2012) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0507-4 · Cited by 42
Deng, W., Bukiya, A. N., Rodríguez‐Menchaca, A. A., Zhang, Z., Baumgarten, C. M., Logothetis, D. E., Levitan, I., & Rosenhouse‐Dantsker, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.306134 · Cited by 41
“On the other hand, vagal stimulation predisposes to atrial fibrillation (AF) (14), which can lead to thromboembolism and stroke (15, 16).”
Background
Metadata
- Authors
- Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care
- Affiliations
- Royal College of Physicians (GB)
- Birmingham City Hospital (GB)
- Corresponding author
- Lip, Gregory Y. H.
- ORCID
- Lip, Gregory Y. H.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2008
- Volume
- 99
- Issue
- 02
- Pages
- 295-304
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2096867256
- Cited by
- 371
- References
- 43
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 6 · 2019: 11 · 2018: 18 · 2017: 18 · 2016: 19 · 2015: 25 · 2014: 23 · 2013: 52 · 2012: 60
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, stroke risk factors, stroke risk stratification, thromboprophylaxis, anticoagulation, antiplatelet therapy, cost-effectiveness, thromboembolism, hypertension, structural heart disease, left ventricular dysfunction, left ventricular hypertrophy, diabetes mellitus
- MeSH terms
- Age Factors, Aged, Algorithms, Anticoagulants, Atrial Fibrillation, Cost-Benefit Analysis, Female, Fibrinolytic Agents, Heart Diseases, Hemorrhage, Humans, Hypertension, Male, Platelet Aggregation Inhibitors, Research Design, Risk Factors, Sex Factors, Smoking, Thromboembolism, Drug Costs, Treatment Outcome, Health Care Costs, Risk Assessment, Patient Selection, Stroke, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.